Clinical Trial Update: Assessment of Gait After Dysport Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing gait after Dysport treatment; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Equinovarus
• Equinovarus

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Equinovarus; Acquired | Phase 4 | Status: COMPLETED | Results posted: 2020-03-02